Bioventus (BVS) Interest & Investment Income (2020 - 2026)

Bioventus (BVS) has 7 years of Interest & Investment Income data on file, last reported at -$4.3 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income rose 42.39% year-over-year to -$4.3 million; the trailing twelve-month figure through Mar 2026 stood at -$23.3 million (up 35.2% YoY), and the FY2025 full-year result was -$26.5 million, up 31.72% from the prior year.
• Interest & Investment Income for Q1 2026 stood at -$4.3 million, up from -$5.3 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $1.5 million in Q2 2022 and bottomed at -$10.6 million in Q3 2023.
• The 5-year median for Interest & Investment Income is -$7.5 million (2025), against an average of -$7.2 million.
• The widest annual swing landed in 2023, when Interest & Investment Income plunged 725.42%; it then surged 42.39% in 2026.
• A 5-year view of Interest & Investment Income shows it stood at -$7.4 million in 2022, then sank by 39.13% to -$10.3 million in 2023, then grew by 12.48% to -$9.0 million in 2024, then surged by 41.02% to -$5.3 million in 2025, then climbed by 18.47% to -$4.3 million in 2026.
• The last three Interest & Investment Income figures came in at -$4.3 million (Q1 2026), -$5.3 million (Q4 2025), and -$6.2 million (Q3 2025), per Business Quant data.

Peer Comparison